[BKAWAN] YoY Annualized Quarter Result on 30-Jun-2016 [#3]

Announcement Date
17-Aug-2016
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2016
Quarter
30-Jun-2016 [#3]
Profit Trend
QoQ- -12.8%
YoY- 70.61%
View:
Show?
Annualized Quarter Result
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Revenue 16,164,345 19,525,318 21,662,306 16,410,882 13,351,073 11,506,165 9,284,646 9.67%
PBT 884,341 1,437,478 1,599,378 2,086,205 1,298,690 1,546,868 1,235,794 -5.42%
Tax -194,202 -373,214 -400,230 -280,424 -276,905 -323,212 -228,062 -2.64%
NP 690,138 1,064,264 1,199,148 1,805,781 1,021,785 1,223,656 1,007,732 -6.11%
-
NP to SH 355,730 525,652 588,849 840,578 492,677 574,289 477,765 -4.79%
-
Tax Rate 21.96% 25.96% 25.02% 13.44% 21.32% 20.89% 18.45% -
Total Cost 15,474,206 18,461,054 20,463,158 14,605,101 12,329,288 10,282,509 8,276,914 10.98%
-
Net Worth 5,781,748 6,495,072 6,612,741 5,755,201 5,176,130 4,664,522 3,833,252 7.08%
Dividend
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Div 79,474 80,285 80,889 81,173 81,578 82,339 83,060 -0.73%
Div Payout % 22.34% 15.27% 13.74% 9.66% 16.56% 14.34% 17.39% -
Equity
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Net Worth 5,781,748 6,495,072 6,612,741 5,755,201 5,176,130 4,664,522 3,833,252 7.08%
NOSH 435,951 435,951 435,951 405,867 407,890 411,696 415,303 0.81%
Ratio Analysis
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
NP Margin 4.27% 5.45% 5.54% 11.00% 7.65% 10.63% 10.85% -
ROE 6.15% 8.09% 8.90% 14.61% 9.52% 12.31% 12.46% -
Per Share
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
RPS 4,067.82 4,863.99 5,356.00 4,043.41 3,273.20 2,794.82 2,235.63 10.48%
EPS 89.52 130.95 145.59 207.11 120.79 139.49 115.04 -4.09%
DPS 20.00 20.00 20.00 20.00 20.00 20.00 20.00 0.00%
NAPS 14.55 16.18 16.35 14.18 12.69 11.33 9.23 7.87%
Adjusted Per Share Value based on latest NOSH - 405,885
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
RPS 4,114.50 4,970.01 5,513.96 4,177.26 3,398.41 2,928.80 2,363.33 9.67%
EPS 90.55 133.80 149.89 213.96 125.41 146.18 121.61 -4.79%
DPS 20.23 20.44 20.59 20.66 20.77 20.96 21.14 -0.73%
NAPS 14.717 16.5327 16.8322 14.6494 13.1754 11.8732 9.7572 7.08%
Price Multiplier on Financial Quarter End Date
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Date 28/06/19 29/06/18 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 -
Price 16.70 17.90 18.90 17.80 18.22 19.80 18.70 -
P/RPS 0.41 0.37 0.35 0.44 0.56 0.71 0.84 -11.26%
P/EPS 18.65 13.67 12.98 8.59 15.08 14.19 16.26 2.31%
EY 5.36 7.32 7.70 11.64 6.63 7.05 6.15 -2.26%
DY 1.20 1.12 1.06 1.12 1.10 1.01 1.07 1.92%
P/NAPS 1.15 1.11 1.16 1.26 1.44 1.75 2.03 -9.03%
Price Multiplier on Announcement Date
30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 CAGR
Date 20/08/19 14/08/18 15/08/17 17/08/16 19/08/15 20/08/14 20/08/13 -
Price 16.00 17.28 19.00 17.96 17.82 19.66 18.26 -
P/RPS 0.39 0.36 0.35 0.44 0.54 0.70 0.82 -11.64%
P/EPS 17.87 13.20 13.05 8.67 14.75 14.09 15.87 1.99%
EY 5.60 7.58 7.66 11.53 6.78 7.10 6.30 -1.94%
DY 1.25 1.16 1.05 1.11 1.12 1.02 1.10 2.15%
P/NAPS 1.10 1.07 1.16 1.27 1.40 1.74 1.98 -9.32%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment